AC Immune
Bryan Robb is a Business Development Analyst with experience in various roles within the biotech and healthcare industry. Bryan holds an MBA from Texas Christian University, with a concentration in corporate and investment finance. Bryan has interned at companies such as Roche, Bios Partners, and UNT Health Science Center, where Bryan gained experience in financial due diligence and business development. Bryan has also conducted research in ophthalmology and Age related Macular Degeneration during their internships at Oregon Health & Science University and Institut de la Vision. Overall, Bryan Robb's diverse educational background and internship experiences have prepared him for their current role at AC Immune.
This person is not in the org chart
This person is not in any teams
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.